HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Remnant lipoproteins and atherosclerosis.

Abstract
A recently developed assay for quantification of remnant-like particle cholesterol has provided considerable evidence that reinforces the concept that elevated levels of plasma remnants are associated with increased cardiovascular disease in different populations and distinct patient groups. In this review, we provide a brief summary of the most recently published studies, emphasizing the clinical relevance of remnant analysis. We discuss recent evidence that sheds light on the mechanisms that may underlie the atherogenicity of remnant lipoproteins. Taken together, these data provide new insight into the significance of remnant lipoproteins in the onset and development of premature atherosclerosis.
AuthorsThB Twickler, G M Dallinga-Thie, M J Chapman, J S Cohn
JournalCurrent atherosclerosis reports (Curr Atheroscler Rep) Vol. 7 Issue 2 Pg. 140-7 (Mar 2005) ISSN: 1523-3804 [Print] United States
PMID15727730 (Publication Type: Journal Article, Review)
Chemical References
  • Biomarkers
  • Lipoproteins
  • Triglycerides
  • remnant-like particle cholesterol
  • Cholesterol
Topics
  • Biomarkers (blood)
  • Cholesterol (blood)
  • Coronary Artery Disease (blood, etiology, pathology)
  • Endothelium, Vascular (metabolism, pathology)
  • Humans
  • Lipoproteins (blood)
  • Prognosis
  • Risk Factors
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: